TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: leg-press strength performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bench-press strength performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IKDC scores at 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of SB vs DB technique
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fe status (sTfR concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Repigmentation of facial lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Biopsy-proven early acute allograft rejection
Endpoint domain: Adverse events/effects
Primary endpoint: 5-year graft survival censored for death with function
Endpoint domain: Mortality/survival
Primary endpoint: Risk of PSA progression
Endpoint domain: Mortality/survival
Primary endpoint: Compliance rates for medical and cloth masks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Requirements for inotropic support at 48 hrs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma insulin-like growth factor-1 (IGF-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Agatston score risk categorization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Illness episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cyclin D(1) expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects totally abstinent from alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cumulative abstinence days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary protein-to-creatinine ratio (uPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 60 minutes PtCO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 60 minutes asthma score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of admission to the hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cervical dilation achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during waiting period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete disappearance of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attempt to perform CPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average compression rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average compression depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maternal cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean forced expiratory volume in one second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Normalization of corrected serum calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Communication skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clearance of SMX and TMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exercise participation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: probability of exercising at or above physical activity guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIN3+ lesions prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Detection of amblyopia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Roland-Morris Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: physical score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Radiographic progression (TSS >0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of Life (QOL) ratings for intermediate activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life (QOL) ratings for social activity
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: clarity of presentation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maintaining interest
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum SOD concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-training fasting glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pooled HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Aerobic capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Volume of drainage after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Visual Analog Scale (VAS) scores
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Oswestry Disability Index (ODI) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: spontaneous recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echocardiographic parameters of LV geometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulmonary health improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exhaled carbon monoxide (CO) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: laryngeal preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: target detection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amplitude of the parietal P3 component
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alpha activity suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute mucositis ≥ grade 3
Endpoint domain: Adverse events/effects
Primary endpoint: late xerostomia ≥ grade 2
Endpoint domain: Adverse events/effects
Primary endpoint: dysphagia ≥ grade 2
Endpoint domain: Adverse events/effects
Primary endpoint: plaque mutans streptococci scores development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to retreatment for intracranial relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder functions improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Clinically significant improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Allergen-specific cytokine responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ulcer healing by day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-1 ulcer shedding on day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Bioequivalence of formulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax comparison between reference and test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of ACR criteria met
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve of the number of ACR criteria met
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SDANN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 10-year cumulative risk of CIN3+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: AIDS event rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: urinary dextromethorphan to dextrorphan metabolic ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of children colonized with VRE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gastrointestinal counts of Lactobacillus spp.
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: relapse rate of malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of leg ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CV safety profile
Endpoint domain: Adverse events/effects
Primary endpoint: Pancreatic fistula rate
Endpoint domain: Adverse events/effects
Primary endpoint: H. pylori eradication success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: levels of antibiotic-resistant bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: bucco-lingual ridge width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower-extremity functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-1 transmission through breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: FIQR scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAT reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RS-Total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean level of theophylline in nasal mucus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean level of theophylline in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean level of theophylline in blood serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median survival (months)
Endpoint domain: Mortality/survival
Primary endpoint: Organoleptic assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-perception of breath (Visual Analog Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of bacterial colonies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of intervention sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Need for further developmental assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Knee flexion at forty-eight hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tolerability of continuous passive motion device
Endpoint domain: Adverse events/effects
Primary endpoint: VAS scores after coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve T(10) dermatome analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of analgesia at T(10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to discharge criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean low-density lipoprotein cholesterol (LDLc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean LDL particle concentration (LDLpc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: vascular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: T2DM risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: average pain intensity score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Received thrombolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: psychosocial well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: treatment-associated mortality
Endpoint domain: Mortality/survival
Primary endpoint: intrathoracic disease recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: cerebral thromboembolic events
Endpoint domain: Adverse events/effects
Primary endpoint: minor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: earlier start of dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Delay of clinical worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resistance of LDL against oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Depth perception issues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSTR percentages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of amenorrhea after 10 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Five-year actuarial rates of late complications
Endpoint domain: Adverse events/effects
Primary endpoint: pachymetric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End-tidal carbon dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Plateau airway pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: N-terminal pro b-type natriuretic peptide (NT-proBNP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Development of allergy by the age of 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Development of eczema by the age of 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infarct size normalized to myocardium at risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak release of Troponin T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative release of Troponin T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fasting endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrence rate of Barrett's esophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postoperative voiding dysfunction lasting at least 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Days of retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Patient preference for retrograde method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average surface pressure on the face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of areas where pressure exceeded 30 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of areas where pressure exceeded 50 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECG QTc prolongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful attempts at sexual intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core temperature at the beginning of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of operative and post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Kujala score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Redislocation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Mean CPK-MM levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean VAS scores for postoperative back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver burden levels
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: 4-hydroxynonenal values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: onset times of sensorial block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motor block durations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative supplementary analgesic requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: UDI (Urogenital Distress Inventory)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: UDI-stress subscale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: UIQ (Urogenital Impact Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: trough FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: patients satisfaction with the method of anesthesia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of myelodepression
Endpoint domain: Adverse events/effects
Primary endpoint: mean bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: soft tissue height
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of ulcers by pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Involvement in work and school
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Renal clearance (CLR) of gabapentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Plasma ergothioneine concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiological status of the root canal system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of pancreatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: disabling stroke at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Days without use of rescue albuterol
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: log10 HIV RNA change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4+ T-cell count increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk of catheter-related infections
Endpoint domain: Adverse events/effects
Primary endpoint: 1-year projected survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Peak microvascular reactivity (PCRH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak PORH values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to definitive abdominal closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intra-abdominal complications
Endpoint domain: Adverse events/effects
Primary endpoint: freedom from late toxicity
Endpoint domain: Mortality/survival
Primary endpoint: local or regional relapse-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Engagement in further outpatient psychotherapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Haemostasis at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of multimodal biopsychosocial treatments for chronic low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Effectiveness of electromyogram feedback for chronic low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Systemic side effects requiring cessation of therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Severe local symptoms of erythema, edema, and pruritus
Endpoint domain: Adverse events/effects
Primary endpoint: Overall patient functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pooled fusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PI(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vo(2)peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Six-minute walk distance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning